JiangXi Tianxin Pharm Co Ltd (603235) — Cash Flow-to-Debt Ratio
JiangXi Tianxin Pharm Co Ltd (603235) has a Cash Flow-to-Debt Ratio of 0.49x as of December 2025, meaning its operating cash flow of CN¥629.36 Million could theoretically repay 0% of its total liabilities (CN¥1.27 Billion) in one year. See JiangXi Tianxin Pharm Co Ltd leverage flexibility ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
JiangXi Tianxin Pharm Co Ltd Cash Flow-to-Debt Ratio (2020–2025)
Historical debt coverage capacity for JiangXi Tianxin Pharm Co Ltd across 6 annual periods. For the full cash flow conversion analysis, see JiangXi Tianxin Pharm Co Ltd (603235) cash conversion ratio.
Annual Cash Flow-to-Debt Ratio for JiangXi Tianxin Pharm Co Ltd (2020–2025)
Year-by-year debt coverage analysis for JiangXi Tianxin Pharm Co Ltd. Check JiangXi Tianxin Pharm Co Ltd cash earnings quality to evaluate the quality of earnings relative to operating cash generation.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.49x | CN¥629.36 Million | CN¥1.27 Billion | ▼ -2.3% |
| 2024 | 0.51x | CN¥499.66 Million | CN¥987.41 Million | ▼ -40.5% |
| 2023 | 0.85x | CN¥729.21 Million | CN¥857.21 Million | ▼ -12.8% |
| 2022 | 0.98x | CN¥606.61 Million | CN¥621.98 Million | ▲ +24.3% |
| 2021 | 0.78x | CN¥818.63 Million | CN¥1.04 Billion | ▲ +18.7% |
| 2020 | 0.66x | CN¥1.16 Billion | CN¥1.76 Billion | — |